INSTATAB Trademark

Trademark Overview

On Friday, March 25, 2011, a trademark application was filed for INSTATAB with the United States Patent and Trademark Office. The USPTO has given the INSTATAB trademark a serial number of 85277030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2013. This trademark is owned by Valeant International (Barbados) SRL. The INSTATAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and al...

General Information

Serial Number85277030
Word MarkINSTATAB
Filing DateFriday, March 25, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValeant International (Barbados) SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB
Party NameValeant International (Barbados) SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Trademark Events

Event DateEvent Description
Tuesday, March 29, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 29, 2011NEW APPLICATION ENTERED
Thursday, June 9, 2011ASSIGNED TO EXAMINER
Sunday, January 1, 2012FINAL REFUSAL E-MAILED
Tuesday, June 14, 2011NON-FINAL ACTION WRITTEN
Tuesday, June 14, 2011NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 14, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 16, 2011ASSIGNED TO LIE
Friday, December 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 1, 2012FINAL REFUSAL WRITTEN
Sunday, January 1, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 4, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 30, 2012EXAMINERS AMENDMENT -WRITTEN
Monday, July 30, 2012EXAMINERS AMENDMENT E-MAILED
Monday, July 30, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 31, 2012EXAMINER'S AMENDMENT ENTERED
Tuesday, July 31, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 31, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 15, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 4, 2012PUBLISHED FOR OPPOSITION
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 16, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 30, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 3, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, June 3, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

instatab substances preparations pharmaceutical treatment prevention alleviation diseases disorders conditions herpes